Farnesyltransferase inhibitors reduce ras activation and ameliorate acetaminophen-induced liver injury in mice†
Article first published online: 20 JUL 2009
Copyright © 2009 American Association for the Study of Liver Diseases
Volume 50, Issue 5, pages 1547–1557, November 2009
How to Cite
Saha, B. and Nandi, D. (2009), Farnesyltransferase inhibitors reduce ras activation and ameliorate acetaminophen-induced liver injury in mice. Hepatology, 50: 1547–1557. doi: 10.1002/hep.23180
Potential conflict of interest: Nothing to report.
- Issue published online: 29 OCT 2009
- Article first published online: 20 JUL 2009
- Accepted manuscript online: 20 JUL 2009 12:00AM EST
- Manuscript Accepted: 8 JUL 2009
- Manuscript Received: 6 MAY 2009
- Government of India
- Student research fellowship from the Council of Scientific and Industrial Research
- 1Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov 2005; 4: 489–499..
- 2Drug-induced acute liver failure. Eur J Gastroenterol Hepatol 2005; 17: 141–143., .
- 3Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci 2006; 89: 31–41., .
- 4Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis? Toxicol Sci 2002; 67: 322–328., , , , .
- 5Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes. HEPATOLOGY 2004; 40: 1170–1179., , , .
- 6Role of inflammation in the mechanism of acetaminophen-induced hepatotoxicity. Expert Opin Drug Metab Toxicol 2005; 1: 389–397..
- 7Histopathology of acetaminophen-induced liver changes: role of interleukin 1 alpha and tumor necrosis factor alpha. Toxicol Pathol 1996; 24: 181–189., , , , .
- 8A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J 2002; 16: 1227–1236., , , , , .
- 9c-Jun N terminal kinase plays a major role in murine acetaminophen hepatotoxicity. Gastroenterology 2006; 131: 165–178., , , , , .
- 10Critical role of c-jun (NH2) terminal kinase in paracetamol-induced acute liver failure. Gut 2007; 56: 982–990., , , , , , et al.
- 11Mitochondrial protection by the JNK inhibitor leflunomide rescues mice from acetaminophen-induced liver injury. HEPATOLOGY 2007; 45: 412–421., , , .
- 12Protective role of c-Jun N-terminal kinase 2 in acetaminophen-induced liver injury. Biochem Biophys Res Commun 2008; 374: 6–10., , , , .
- 13Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem 2008; 283: 13565–13577., , , , , .
- 14Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation. Gastroenterology 2008; 135: 1311–1321., , , , , , et al.
- 15Increasing complexity of the Ras signaling pathway. J Biol Chem 1998; 273: 19925–19928., .
- 16Involvement of oxidative and nitrosative stress in modulation of gene expression and functional responses by IFNgamma. Int Immunol 2007; 19: 867–879., , .
- 17Organelle isolation: functional mitochondria from mouse liver, muscle and cultured fibroblasts. Nat Protoc 2007; 2: 287–295., , .
- 18A colorimetric micro-method for the determination of glutathione. Biochem J 1965; 94: 705–711., .
- 19Arachidonic acid interaction with the mitochondrial electron transport chain promotes reactive oxygen species generation. Free Rad Biol Med 1999; 27: 51–59., , , .
- 20Manumycin and gliotoxin derivative KT7595 block Ras farnesylation and cell growth but do not disturb lamin farnesylation and localization in human tumour cells. Br J Cancer 1997; 76: 1001–1010., , , , , , et al.
- 21Farnesyl transferase inhibitors in clinical development. Expert Opin Investig Drugs 2003; 12: 943–954., , .
- 22Inhibitors of sphingolipid metabolism enzymes. Biochim Biophys Acta 2006; 1758: 1957–1977., , , , .
- 23Protection from acetaminophen-induced liver damage by the synergistic action of low doses of the poly(ADP-ribose) polymerase-inhibitor nicotinamide and the antioxidant N-acetylcysteine or the amino acid L-methionine. Gen Pharmacol 1997; 28: 257–263., , , , , .
- 24Prevention of acetaminophen (APAP)-induced hepatotoxicity by leflunomide via inhibition of APAP biotransformation to N-acetyl-p-benzoquinone imine. Toxicol Lett 2008; 180: 174–181., , .
- 25Inhibition of oncogene-induced inflammatory chemokines using a farnesyltransferase inhibitor. J Inflamm (Lond) 2008; 5: 3., , , .
- 26Interleukin 6 and hepatocyte regeneration in acetaminophen toxicity in the mouse. Biochem Biophys Res Commun 2003; 309: 857–863., , , .
- 27Effect of platelet-activating factor (PAF) receptor antagonist (BN52021) on acetaminophen-induced acute liver injury and regeneration in rats. Liver Int 2006; 26: 97–105., , , , , .
- 28Prolonged treatment with N- acetylcystine delays liver recovery from acetaminophen hepatotoxicity. Crit Care 2009; 13: R55., , , , .
- 29Immunohistochemical detection of ras and myc oncogene expression in regenerating rat liver. Toxicol Lett 1992; 60: 119–129., , .
- 30Inhibition of the Ras oncoprotein reduces proliferation of hepatocytes in vitro and in vivo in rats. Clin Sci 2008; 114: 73–83., , , , .
- 31Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 1997; 275: 1649–1652., , , , , et al.
- 32Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem 1999; 274: 7936–7940., , , , , et al.
- 33Anti-inflammatory activity in vitro and in vivo of the protein farnesyltransferase inhibitor tipifarnib. J Pharmacol Exp Ther 2006; 317: 53–60., , , , , .
- 34Inhibition of farnesyltransferase prevents collagen-induced arthritis by down-regulation of inflammatory gene expression through suppression of p21(ras)-dependent NF-kappaB activation. J Immunol 2004; 173: 1276–1283., , , , , , et al.
- 35Farnesyltransferase inhibitor, manumycin a, prevents atherosclerosis development and reduces oxidative stress in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2007; 27: 1390–1395., , .
- 36Inhibition of corneal inflammation by the topical use of Ras farnesyltransferase inhibitors: selective inhibition of macrophage localization. Invest Ophthalmol Vis Sci 1998; 39: 2245–2251., , , , , , et al.